Experimental duel angiogenic inhibitor outperforms ranibizumab for DME
- Posted on: Oct 16 2019
- Leave a response
This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME).
Source: AAO
Posted in: Uncategorized
This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME).
Source: AAO
Posted in: Uncategorized
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »